The FDA hit a Farmingdale, New York generic drugmaker with a Form 483 for a large number of violations, including inadequate complaint investigations and multiple issues with testing.

Pharma giant Pfizer was taken to task in an FDA warning letter over testing violations at its Visakhapatnam, Andhra Pradesh sterile injectable drug facility.

The FDA hit a drug compounder in Hallandale, Florida with a warning letter for failing to properly maintain the facility and other serious violations.